TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge

被引：0
|
作者：
Sabine Grill
Juliane Ramser
Heide Hellebrand
Nicole Pfarr
Melanie Boxberg
Christine Brambs
Nina Ditsch
Alfons Meindl
Eva Groß
Thomas Meitinger
Marion Kiechle
Anne S. Quante
机构：
[1] University Hospital Klinikum Rechts der Isar,Department of Gynecology and Obstetrics
[2] Technical University Munich (TUM),Institute of Pathology
[3] Technical University Munich (TUM),Department of Gynecology and Obstetrics
[4] University Hospital of Augsburg,Department of Obstetrics and Gynecology
[5] Ludwig-Maximilians-University of Munich,Institute of Human Genetics
[6] University Hospital Klinikum Rechts der Isar,undefined
[7] Technical University Munich (TUM),undefined
来源：
Archives of Gynecology and Obstetrics | 2021年 / 303卷
关键词：
germline mutation; p53; Li-fraumeni-syndrome; Cancer surveillance; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1557 / 1567
页数：10
相关论文
共 50 条
  • [1] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Grill, Sabine
    Ramser, Juliane
    Hellebrand, Heide
    Pfarr, Nicole
    Boxberg, Melanie
    Brambs, Christine
    Ditsch, Nina
    Meindl, Alfons
    Gross, Eva
    Meitinger, Thomas
    Kiechle, Marion
    Quante, Anne S.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (06) : 1557 - 1567
  • [2] Clinical implications of germline mutations in breast cancer: TP53
    Katherine Schon
    Marc Tischkowitz
    [J]. Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
  • [3] Clinical implications of germline mutations in breast cancer: TP53
    Schon, Katherine
    Tischkowitz, Marc
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
  • [4] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [5] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [6] High prevalence of gastric cancer in families with germline TP53 mutations
    Masciari, Serena
    Dewanwala, Akritti
    Stoffel, Elena M.
    Li, Frederick
    Garber, Judy E.
    Syngal, Sapna
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A67 - A67
  • [7] Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families
    Manoukian, Siranoush
    Peissel, Bernard
    Pensotti, Valeria
    Barile, Monica
    Cortesi, Laura
    Stacchiotti, Silvia
    Terenziani, Monica
    Barbera, Floriana
    Pasquini, Graziella
    Frigerio, Simona
    Pierotti, Marco A.
    Radice, Paolo
    Della-Torre, Gabriella
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 601 - 606
  • [8] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
    Sheng, Shuyan
    Xu, Ye
    Guo, Yonghai
    Yao, Lu
    Hu, Li
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
  • [9] Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families
    Balz, V
    Prisack, HB
    Bier, H
    Bojar, H
    [J]. CANCER GENETICS AND CYTOGENETICS, 2002, 138 (02) : 120 - 127
  • [10] Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne
    Kast, K.
    Rhiem, K.
    Larsen, M.
    Wappenschmidt, B.
    Schmutzler, R.
    [J]. CANCER MEDICINE, 2024, 13 (03):
12345